"/> Novus Biologicals™ Peptide bloquant d’anticorps LY… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps LYRM2

Réf. : BL-RE-081837Réf. fabricant : 18299135 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
57226
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77137. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the carboxy terminus of human LYRM2.

Points forts

Source

Synthetic

(Accession #: NP_065199) The LYRM2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-081837
Réf. fabricant18299135
Gene ID (Entrez)57226
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77137. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneDJ122O8.2, FLJ18193, FLJ18317, FLJ21130, LYR motif containing 2, LYR motif-containing protein 2, MGC104253
Symbole de gène(s)LYRM2
Type de produitLYRM2
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the carboxy terminus of human LYRM2
Une question, une configuration particulière ?
Contactez-nous pour un devis.